Debt remains stable at $13.2B with D/E improving to 1.52, but goodwill of $11.4B (37% of assets) poses impairment risk if USPI growth falters.
Tenet Healthcare Corporation (THC) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | May'02 | May'00 | May'99 | May'98 | May'97 | May'96 | May'95 |
|---|
| Total Current Assets | 7.83B | 7.85B | 7.68B | 7.17B | 5.98B | 7.08B | 7.15B | 5.08B | 4.64B | 5.57B | 5.26B | 5.17B | 4.72B | 3.71B | 2.68B | 2.36B | 2.31B | 2.47B | 2.71B | 2.56B | 3.02B | 3.51B | 3.99B | 4.25B | 3.27B | 3.59B | 3.52B | 2.89B | 2.39B | 1.54B | 1.62B |
| Cash & Short-Term Investments | 2.17B | 2.88B | 3.02B | 1.23B | 858M | 2.36B | 2.45B | 262M | 411M | 611M | 716M | 356M | 193M | 113M | 364M | 113M | 406M | 703M | 523M | 592M | 823M | 1.38B | 771M | 742M | 166M | 245M | 154M | 23M | 35M | 89M | 155M |
| Cash Only | 2.17B | 2.88B | 3.02B | 1.23B | 858M | 2.36B | 2.45B | 262M | 411M | 611M | 716M | 356M | 193M | 113M | 364M | 113M | 405M | 690M | 507M | 572M | 784M | 1.37B | 654M | 619M | 63M | 135M | 31M | 23M | 35M | 89M | 155M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 13M | 16M | 20M | 39M | 5M | 117M | 123M | 103M | 104M | 123M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.61B | 2.56B | 3.05B | 3.4B | 3.46B | 3.31B | 3.35B | 3.26B | 3.09B | 3.02B | 3.43B | 3.09B | 2.4B | 1.89B | 1.34B | 1.28B | 1.29B | 1.2B | 1.46B | 1.56B | 1.73B | 1.6B | 2.22B | 2.42B | 2.38B | 2.39B | 2.47B | 2.32B | 1.74B | 1.35B | 1.04B |
| Days Sales Outstanding | 48.34 | 43.93 | 53.94 | 60.47 | 65.9 | 61.93 | 69.34 | 64.47 | 61.65 | 57.57 | 63.84 | 60.49 | 52.78 | 62.12 | 53.48 | 54.2 | 56.79 | 48.47 | 62.07 | 70.26 | 74.57 | 70.14 | 92.5 | 87.69 | 62.36 | 72.25 | 78.92 | 77.76 | 64.26 | 56.53 | 49.26 |
| Inventory | 338M | 348M | 346M | 411M | 405M | 384M | 368M | 310M | 305M | 289M | 326M | 309M | 276M | 262M | 153M | 161M | 156M | 153M | 161M | 183M | 184M | 190M | 188M | 224M | 220M | 223M | 218M | 214M | 193M | 128M | 116M |
| Days Inventory Outstanding | 7.87 | 33.6 | 10.14 | 11.77 | 12.19 | 11.47 | 11.77 | 9.62 | 9.55 | 8.52 | 9.53 | 9.44 | 9.46 | 13.37 | 9.61 | 37.96 | 36.93 | 10.29 | 11.11 | 13.31 | 12.65 | 13.03 | 12.84 | - | - | 19.02 | 19.31 | 20.2 | 20.44 | 5.96 | 6.67 |
| Other Current Assets | 2.71B | 2.05B | 895M | 1.73B | 856M | 769M | 982M | 1.25B | 827M | 1.65B | 783M | 1.42B | 1.1B | 1.43B | 828M | 725M | 394M | 349M | 481M | 138M | 188M | 340M | 815M | 867M | 507M | 460M | 678M | 1.26B | 911M | 817M | 723M |
| Total Non-Current Assets | 22.85B | 21.83B | 21.25B | 21.14B | 21.18B | 20.5B | 19.96B | 18.27B | 17.77B | 17.81B | 19.44B | 18.51B | 13.42B | 12.42B | 6.36B | 6.11B | 6.19B | 5.48B | 5.46B | 5.83B | 5.51B | 6.3B | 6.09B | 8.05B | 10.15B | 9.57B | 9.76B | 9.94B | 9.31B | 6.79B | 6.29B |
| Property, Plant & Equipment | 6.26B | 7.45B | 7.09B | 7.32B | 7.59B | 7.43B | 7.75B | 7.79B | 6.99B | 7.03B | 8.05B | 7.92B | 7.73B | 7.69B | 4.29B | 4.35B | 4.3B | 4.31B | 4.29B | 4.64B | 4.3B | 4.62B | 4.82B | 5.56B | 6.31B | 5.89B | 5.84B | 6.01B | 5.49B | 3.65B | 3.32B |
| Fixed Asset Turnover | 3.35x | 2.86x | 2.92x | 2.81x | 2.53x | 2.62x | 2.27x | 2.37x | 2.62x | 2.73x | 2.44x | 2.35x | 2.15x | 1.44x | 2.12x | 1.99x | 1.92x | 2.09x | 2.00x | 1.74x | 1.97x | 1.80x | 1.82x | 1.81x | 2.21x | 2.04x | 1.95x | 1.81x | 1.80x | 2.38x | 2.32x |
| Goodwill | 11.44B | 11.2B | 10.69B | 10.31B | 10.12B | 9.26B | 8.81B | 7.25B | 7.28B | 7.02B | 7.42B | 6.97B | 3.91B | 3.04B | 916M | 736M | 652M | 607M | 609M | 607M | 601M | 800M | 800M | 0 | 3.32B | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.28B | 1.35B | 1.4B | 1.37B | 1.42B | 1.5B | 1.6B | 1.6B | 1.73B | 1.77B | 1.84B | 1.68B | 1.28B | 1.19B | 650M | 489M | 442M | 379M | 323M | 293M | 231M | 241M | 144M | 2.11B | 166M | 3.33B | 3.37B | 3.41B | 3.15B | 2.57B | 2.51B |
| Long-Term Investments | 7.35B | 1.44B | 1.81B | 1.89B | 1.83B | 2.03B | 1.23B | 1.19B | 1.23B | 1.28B | 984M | 1.18B | 133M | 118M | 162M | 45M | 53M | 57M | 242M | 288M | 0 | 380M | 155M | 185M | 360M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.8B | 307M | 194M | 180M | 192M | 224M | 239M | 264M | 229M | 263M | 266M | 0 | 447M | 486M | 0 | 184M | 181M | 125M | 31M | 35M | 383M | 156M | 166M | -60M | -160M | 344M | 546M | 515M | 678M | 565M | 464M |
| Total Assets | 30.68B | 29.68B | 28.94B | 28.31B | 27.16B | 27.58B | 27.11B | 23.35B | 22.41B | 23.39B | 24.7B | 23.68B | 18.14B | 16.13B | 9.04B | 8.46B | 8.5B | 7.95B | 8.17B | 8.39B | 8.54B | 9.81B | 10.08B | 12.3B | 13.42B | 13.16B | 13.28B | 12.83B | 11.71B | 8.33B | 7.92B |
| Asset Turnover | 0.72x | 0.72x | 0.71x | 0.73x | 0.71x | 0.71x | 0.65x | 0.79x | 0.82x | 0.82x | 0.79x | 0.79x | 0.92x | 0.69x | 1.01x | 1.02x | 0.97x | 1.13x | 1.05x | 0.96x | 0.99x | 0.85x | 0.87x | 0.82x | 1.04x | 0.92x | 0.86x | 0.85x | 0.85x | 1.04x | 0.97x |
| Asset Growth % | 16.33% | 2.56% | 2.2% | 4.26% | -1.53% | 1.75% | 16.08% | 4.2% | -4.17% | -5.33% | 4.3% | 30.54% | 12.47% | 78.35% | 6.88% | -0.45% | 6.88% | -2.7% | -2.61% | -1.71% | -12.97% | -2.64% | -18.05% | -8.38% | 1.99% | -0.86% | 3.44% | 9.64% | 40.48% | 5.23% | 114.17% |
| Total Current Liabilities | 5.57B | 4.46B | 4.31B | 4.76B | 4.48B | 5.11B | 4.85B | 4.21B | 3.86B | 4.33B | 4.03B | 4.31B | 3.58B | 2.93B | 1.76B | 1.81B | 1.73B | 1.78B | 1.95B | 2.05B | 1.93B | 2.29B | 2.13B | 2.39B | 2.23B | 1.91B | 1.93B | 1.77B | 1.87B | 1.13B | 1.36B |
| Accounts Payable | 1.37B | 1.36B | 1.29B | 1.41B | 1.5B | 1.3B | 1.21B | 1.2B | 1.09B | 1.1B | 1.19B | 1.38B | 1.07B | 1.08B | 722M | 760M | 720M | 739M | 686M | 780M | 775M | 857M | 937M | 987M | 803M | 775M | 605M | 713M | 657M | 540M | 530M |
| Days Payables Outstanding | 31.04 | 131.32 | 37.92 | 40.33 | 45.27 | 38.84 | 38.61 | 37.35 | 34.24 | 32.3 | 34.75 | 42.14 | 36.56 | 55.35 | 45.37 | 179.2 | 170.43 | 49.71 | 47.33 | 56.74 | 53.3 | 58.76 | 63.99 | - | - | 66.09 | 53.6 | 67.3 | 69.59 | 25.16 | 30.47 |
| Short-Term Debt | 160M | 79M | 296M | 120M | 145M | 135M | 145M | 171M | 182M | 146M | 191M | 127M | 112M | 153M | 94M | 66M | 67M | 2M | 2M | 1M | 22M | 19M | 41M | 18M | 35M | 25M | 36M | 45M | 10M | 28M | 120M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 110M | 959M | 659M | 61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.1B | 1.81B | 2.55B | 3.01B | 2.5B | 2.51B | 2.59B | 2.52B | 2.23B | 2.75B | 2.3B | 2.3B | 2.05B | 1.66B | 822M | 813M | 815M | 469M | 968M | 1.02B | 537M | 538M | 610M | 669M | 875M | 758M | 1.28B | 1.26B | 1.04B | 1.3B | 891M |
| Current Ratio | 1.41x | 1.76x | 1.78x | 1.51x | 1.34x | 1.38x | 1.47x | 1.21x | 1.20x | 1.29x | 1.30x | 1.20x | 1.32x | 1.27x | 1.52x | 1.30x | 1.34x | 1.39x | 1.39x | 1.25x | 1.57x | 1.53x | 1.87x | 1.77x | 1.47x | 1.88x | 1.83x | 1.64x | 1.28x | 1.36x | 1.20x |
| Quick Ratio | 1.35x | 1.68x | 1.70x | 1.42x | 1.25x | 1.31x | 1.40x | 1.13x | 1.12x | 1.22x | 1.22x | 1.13x | 1.24x | 1.18x | 1.43x | 1.21x | 1.25x | 1.30x | 1.31x | 1.16x | 1.48x | 1.45x | 1.79x | 1.68x | 1.37x | 1.76x | 1.71x | 1.51x | 1.18x | 1.25x | 1.11x |
| Cash Conversion Cycle | 25.17 | -53.79 | 26.16 | 31.91 | 32.82 | 34.56 | 42.5 | 36.74 | 36.97 | 33.79 | 38.63 | 27.78 | 25.68 | 20.14 | 17.72 | -87.04 | -76.71 | 9.05 | 25.85 | 26.84 | 33.92 | 24.41 | 41.35 | - | - | 25.18 | 44.64 | 30.66 | 15.11 | 37.33 | 25.46 |
| Total Non-Current Liabilities | 16.41B | 16.24B | 16.08B | 18.04B | 18.07B | 18.21B | 19.37B | 17.16B | 16.45B | 16.65B | 17.19B | 16.15B | 13.38B | 12.08B | 6.05B | 5.14B | 4.96B | 5.47B | 6.12B | 6.29B | 6.35B | 6.5B | 6.22B | 5.54B | 5.9B | 7.18B | 7.26B | 7.51B | 6.61B | 4.56B | 4.58B |
| Long-Term Debt | 13.09B | 13.09B | 12.69B | 14.88B | 14.93B | 15.51B | 15.57B | 14.58B | 14.64B | 14.79B | 15.06B | 14.38B | 11.51B | 10.7B | 5.16B | 4.29B | 4B | 4.27B | 4.78B | 4.77B | 4.76B | 4.78B | 4.39B | 4.04B | 4.32B | 4.2B | 5.78B | 6.39B | 5.83B | 5.02B | 4.42B |
| Capital Lease Obligations | 0 | 0 | 1.34B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 1.03B | 240M | 227M | 326M | 217M | 36M | 29M | 27M | 36M | 36M | 279M | 37M | 0 | 0 | 0 | 0 | 0 | 148M | 101M | 119M | 107M | 212M | 311M | 4M | 546M | 491M | 427M | 423M | 308M | 394M | 301M |
| Other Non-Current Liabilities | 3B | 2.91B | 1.81B | 2.84B | 2.91B | 2.65B | 2.85B | 2.59B | 1.76B | 1.82B | 1.85B | 1.73B | 1.68B | 1.44B | 889M | 845M | 959M | 1.05B | 1.2B | 1.4B | 1.48B | 1.5B | 1.56B | 1.5B | 1.03B | 994M | 1.05B | 1.05B | 1.26B | 1.28B | 1.1B |
| Total Liabilities | 21.98B | 20.7B | 20.39B | 22.8B | 22.55B | 23.32B | 24.22B | 21.36B | 20.3B | 20.98B | 21.23B | 20.46B | 16.95B | 15.01B | 7.81B | 6.95B | 6.68B | 7.26B | 8.07B | 8.34B | 8.28B | 8.79B | 8.35B | 7.94B | 8.12B | 9.1B | 9.19B | 9.28B | 8.48B | 5.7B | 5.93B |
| Total Debt | 13.25B | 13.17B | 14.33B | 15B | 15.08B | 15.65B | 15.72B | 14.75B | 14.83B | 14.94B | 15.26B | 14.51B | 11.62B | 10.85B | 5.25B | 4.36B | 4.06B | 4.27B | 4.78B | 4.77B | 4.78B | 4.8B | 4.44B | 4.06B | 4.36B | 4.23B | 5.82B | 6.44B | 5.84B | 5.05B | 4.54B |
| Net Debt | 11.08B | 10.29B | 11.31B | 13.77B | 14.22B | 13.28B | 13.27B | 14.49B | 14.41B | 14.33B | 14.54B | 14.15B | 11.42B | 10.74B | 4.89B | 4.25B | 3.66B | 3.58B | 4.27B | 4.2B | 4B | 3.43B | 3.78B | 3.44B | 4.29B | 4.17B | 5.79B | 6.41B | 5.82B | 5.01B | 4.43B |
| Debt / Equity | 1.52x | 1.47x | 1.68x | 2.72x | 3.27x | 3.68x | 5.44x | 7.42x | 7.04x | 6.21x | 4.39x | 4.50x | 9.80x | 9.64x | 4.26x | 2.89x | 2.23x | 6.13x | 46.41x | 88.37x | 18.11x | 4.70x | 2.56x | 0.93x | 0.82x | 1.04x | 1.42x | 1.81x | 1.81x | 1.92x | 2.29x |
| Debt / EBITDA | 2.91x | 3.06x | 2.11x | 4.44x | 4.75x | 4.20x | 5.52x | 6.18x | 6.08x | 7.53x | 7.27x | 7.74x | 6.55x | 8.98x | 4.45x | 4.09x | 3.84x | 4.35x | 1.79x | 1.88x | - | 13.12x | - | - | 1.65x | 2.03x | 2.97x | 3.65x | 3.26x | 6.87x | 4.01x |
| Net Debt / EBITDA | 2.43x | 2.39x | 1.67x | 4.08x | 4.48x | 3.56x | 4.66x | 6.07x | 5.91x | 7.22x | 6.93x | 7.55x | 6.44x | 8.89x | 4.15x | 3.98x | 3.46x | 3.65x | 1.60x | 1.66x | - | 9.37x | - | - | 1.62x | 2.00x | 2.95x | 3.64x | 3.25x | 6.82x | 3.91x |
| Interest Coverage | 5.08x | 4.41x | 7.35x | 2.79x | 2.51x | 3.05x | 1.67x | 1.32x | 1.63x | 0.90x | 1.25x | 1.16x | 1.19x | 0.67x | 1.81x | 1.44x | 1.37x | 1.46x | 1.13x | 0.74x | -0.54x | -0.02x | -0.48x | -0.40x | 4.04x | 1.40x | 1.20x | 1.26x | 2.22x | - | 15.13x |
| Total Equity | 8.7B | 8.97B | 8.55B | 5.51B | 4.61B | 4.26B | 2.89B | 1.99B | 2.11B | 2.4B | 3.48B | 3.22B | 1.19B | 1.13B | 1.23B | 1.51B | 1.82B | 697M | 103M | 54M | 264M | 1.02B | 1.73B | 4.36B | 5.3B | 4.07B | 4.09B | 3.56B | 3.22B | 2.64B | 1.99B |
| Equity Growth % | 19.79% | 4.98% | 55.17% | 19.53% | 8.25% | 47.35% | 45.25% | -5.6% | -12.39% | -30.79% | 7.79% | 171.84% | 5.42% | -8.83% | -18.17% | -17.1% | 160.98% | 576.7% | 90.74% | -79.55% | -74.14% | -41.05% | -60.28% | -17.73% | 30.37% | -0.56% | 14.92% | 10.36% | 22.31% | 32.73% | 50.45% |
| Book Value per Share | 103.62 | 98.79 | 87.32 | 52.56 | 41.70 | 39.21 | 27.19 | 19.24 | 20.28 | 23.91 | 34.99 | 32.51 | 11.83 | 11.07 | 11.33 | 12.43 | 12.98 | 5.50 | 0.86 | 0.46 | 2.24 | 8.71 | 14.86 | 37.40 | 43.21 | 34.43 | 34.79 | 30.46 | 28.27 | 32.91 | 26.34 |
| Total Shareholders' Equity | 4.66B | 4.22B | 4.17B | 1.61B | 1.14B | 1.03B | 28M | -371M | -119M | -147M | 417M | 691M | 651M | 755M | 1.14B | 1.42B | 1.77B | 646M | 103M | 54M | 264M | 1.02B | 1.73B | 4.36B | 5.3B | 4.07B | 4.09B | 3.56B | 3.22B | 2.64B | 1.99B |
| Common Stock | 8M | 8M | 8M | 8M | 8M | 8M | 7M | 7M | 7M | 7M | 7M | 7M | 7M | 7M | 7M | 27M | 27M | 27M | 26M | 26M | 26M | 26M | 26M | 26M | 25M | 24M | 24M | 0 | 0 | 0 | 0 |
| Retained Earnings | 5.94B | 4.42B | 3.01B | -192M | -803M | -1.21B | -2.13B | -2.47B | -2.24B | -2.39B | -1.74B | -1.55B | -1.41B | -1.42B | -1.29B | -1.44B | -1.52B | -2.67B | -2.85B | -2.88B | -2.61B | -1.81B | -930M | 1.71B | 2.51B | 1.63B | 1.57B | 1.08B | 819M | 1.09B | 740M |
| Treasury Stock | -6.31B | -4.94B | -3.54B | -2.86B | -2.66B | -2.41B | -2.41B | -2.41B | -2.41B | -2.42B | -2.42B | -2.42B | -2.38B | -2.38B | -1.98B | -1.85B | -1.48B | -1.48B | -1.48B | -1.48B | -1.48B | -1.48B | -1.48B | -1.49B | -257M | -70M | -70M | -70M | 0 | 0 | 0 |
| Accumulated OCI | -177M | -181M | -180M | -181M | -181M | -233M | -281M | -257M | -223M | -204M | -258M | -164M | -182M | -24M | -68M | -52M | -43M | -32M | -37M | -28M | -45M | -39M | -13M | -8M | -44M | -70M | 2.56B | -1.76B | -1.43B | -950M | -824M |
| Minority Interest | 4.04B | 4.75B | 4.38B | 3.9B | 3.47B | 3.23B | 2.86B | 2.36B | 2.23B | 2.55B | 3.06B | 2.53B | 535M | 370M | 91M | 85M | 53M | 51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying THC stock.
As of 2025, Tenet Healthcare Corporation (THC) had total assets of $29.68B including $7.85B in current assets.
Tenet Healthcare Corporation (THC) carries total debt of $13.17B, offset by $2.88B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Tenet Healthcare Corporation (THC) has total shareholders' equity (book value) of $4.22B ($98.79 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Tenet Healthcare Corporation (THC) reported a current ratio of 1.76x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
USPI concentration and revenue deferrals
Metrics are mathematically derived from official filings.
Equity Builds on Retained Earnings
Tenet's equity rose from $3.5B in Q1 2024 to $4.7B in Q2 2026, driven by retained earnings growth, per reported balance sheet data, signaling a strengthening financial base.
The consistent increase in retained earnings from $2.0B to $5.9B over the period indicates that the company is retaining profits to fund operations and growth, rather than relying on external financing. This trend suggests improving internal capital generation, which may support future investments in the high-margin USPI segment without additional leverage.
Stable Debt, Declining Leverage
Total debt remained flat at $13.2B over the last ten quarters, while equity grew, reducing D/E from 1.68 to 1.52, as per financial statements, indicating a gradual deleveraging.
The static debt level combined with rising equity suggests that Tenet is not taking on additional debt to fund its expansion, which may reflect a disciplined capital allocation strategy. The D/E ratio, though still elevated, is trending downward, implying improved financial flexibility and reduced refinancing risk, especially if interest rates remain elevated.
Goodwill Dominates Asset Base
Goodwill increased to $11.4B, representing 37% of total assets, while PPE net declined to $6.3B, per reported figures, highlighting the importance of acquisitions over physical assets.
The substantial goodwill balance, largely from the USPI acquisition, indicates that Tenet's asset base is heavily reliant on intangible value. This raises impairment risk if the ambulatory segment underperforms, but the growth in USPI's earnings may justify the carrying value. The decline in PPE suggests a shift toward asset-light operations, consistent with the strategic focus on ASCs.
Retained Earnings Drive Equity Growth
Equity expanded from $3.5B to $4.7B, with retained earnings growing from $2.0B to $5.9B, per balance sheet data, indicating strong profit retention and minimal dilution.
The growth in retained earnings outpaces the increase in total equity, suggesting that the company is not heavily relying on new share issuance, which would dilute existing shareholders. This is a positive signal for equity quality, as it implies that the balance sheet strengthening is organic and not artificially inflated by accounting adjustments.
Liquidity Buffer Remains Adequate
Current ratio improved to 1.41 in Q2 2026 from 1.44 in Q1 2024, with cash at $2.2B, per reported data, providing a modest buffer against short-term obligations.
While the current ratio is above 1, indicating that current assets exceed current liabilities, the cash position has declined from $2.5B to $2.2B over the period. This suggests that cash is being deployed into operations or acquisitions, but the liquidity buffer remains sufficient to cover near-term liabilities. Investors should monitor whether the declining cash trend continues, as it could strain liquidity if operating cash flow weakens.
Goodwill Impairment Risk Looms
Goodwill of $11.4B, over 37% of total assets, per balance sheet data, poses a significant impairment risk if USPI's growth falters, potentially eroding equity.
The large goodwill balance, primarily from the USPI acquisition, is a non-cash asset that may be subject to impairment if the ambulatory segment's cash flows do not meet projections. Given the concentration risk in USPI, any disruption to surgical volumes or integration issues could trigger a write-down, which would directly reduce equity and potentially impact debt covenants. This risk is not apparent from headline leverage metrics but warrants close monitoring.